New Synthetic Molecules Trigger Immune Response To HIV And Prostate Cancer

November 8, 2009 by admin 

Researchers at Yale University have developed synthetic molecules capable of enhancing the body’s immune response to HIV and HIV-infected cells, as well as to prostate cancer cells. Their findings, published online in the Journal of the American Chemical Society, could lead to novel therapeutic approaches for these diseases.

Source: New Synthetic Molecules Trigger Immune Response To HIV And Prostate Cancer

Comments

Comments are closed.